Skyline Medical Announces Exclusive Distribution Agreement with GLG Pharma to Distribute STREAMWAY in Poland and Other Central European Countries
Nov 2 16
Skyline Medical Inc. announced that it has agreed to grant GLG Pharma, LLC ('GLG') exclusive rights to market and distribute the STREAMWAY® System in Poland and certain other countries in Central Europe. This builds upon a previously announced arrangement granting GLG exclusive rights to market and distribute STREAMWAY in the U.K. and an initial agreement to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures. GLG will be responsible for all sales and marketing activities, including hiring and training the appropriate number of direct sales representatives to cover the 3,800 operating rooms in Poland. Marketing is expected to begin immediately upon receipt of the CE Mark and will be managed from GLG’s facility in Gdansk, Poland. The agreement will also include the Czech Republic, Latvia, Estonia and Lithuania, with sales activities expected to begin in those countries soon after the introduction in Poland.
Umowę ze Skyline Medical Announces Exclusive Distribution podpisali już we wrzesniu b.r., ale jest tak duże zainteresowanie spółką, że informacja przeszła bez echa.
pozdro.